Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.
Roffi L, Redaelli A, Colloredo G, Minola E, Donada C, Picciotto A, Riboli P, Del Poggio P, Rinaldi G, Paris B, Fornaciari G, Giusti M, Marin R, Morales R, Sangiovanni A, Belloni G, Pozzi M, Poli G, Mascoli N, Corradi C, Pioltelli P, Scalori A, Mancia G. Roffi L, et al. Among authors: colloredo g. Eur J Gastroenterol Hepatol. 2001 May;13(5):501-6. doi: 10.1097/00042737-200105000-00007. Eur J Gastroenterol Hepatol. 2001. PMID: 11396528 Review.
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.
Roffi L, Ricci A, Ogliari C, Scalori A, Minola E, Colloredo G, Donada C, Ceriani R, Rinaldi G, Paris B, Fornaciari G, Morales R, Del Poggio P, Sangiovanni A, Buonocore M, Bellia V, Riboli P, Nava MC, Panizzuti F, Piperno A, Pozzi M, Pioltelli P, Mancia G. Roffi L, et al. Among authors: colloredo g. J Hepatol. 1998 Nov;29(5):701-6. doi: 10.1016/s0168-8278(98)80249-3. J Hepatol. 1998. PMID: 9833906
Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.
Roffi L, Colloredo G, Pioltelli P, Bellati G, Pozzpi M, Parravicini P, Bellia V, Del Poggio P, Fornaciari G, Ceriani R, Ramella G, Corradi C, Rossini A, Bruno S; Gruppo Epatologico Lombardo. Roffi L, et al. Among authors: colloredo g. Antivir Ther. 2008;13(5):663-73. Antivir Ther. 2008. PMID: 18771050 Clinical Trial.
HCV genotypes and breakthrough in patients treated with recombinant alpha interferon.
Roffi L, Colloredo G, Brugnetti B, Bellati G, Ricci A, Scalori A, Antonelli G, Panizzuti F, Pozzi M, Pioltelli P, Mancia G. Roffi L, et al. Among authors: colloredo g. Am J Gastroenterol. 1998 Sep;93(9):1602-3. doi: 10.1111/j.1572-0241.1998.01602.x. Am J Gastroenterol. 1998. PMID: 9732970 No abstract available.
Breakthrough of interferon therapy.
Scalori A, Ricci A, Bellati G, Colloredo G, Roffi L. Scalori A, et al. Among authors: colloredo g. Am J Gastroenterol. 1996 Oct;91(10):2249-50. Am J Gastroenterol. 1996. PMID: 8855768 No abstract available.
Epidemiology and outcome of hepatocellular carcinoma in Lombardy.
Borzio M, Colloredo G, Pioltelli P, Quagliuolo M; Gruppo Epatologico Lombardo (GEL). Borzio M, et al. Among authors: colloredo g. Dig Liver Dis. 2007 Nov;39(11):1011-7. doi: 10.1016/j.dld.2007.06.018. Epub 2007 Oct 23. Dig Liver Dis. 2007. PMID: 17936698
50 results